Free shipping on all orders over $ 500

PROTAC IRAK4 degrader-7 

Cat. No. M29635

All AbMole products are for research use only, cannot be used for human consumption.

PROTAC IRAK4 degrader-7  Structure
Synonym:

KT-474; SAR444656

Size Price Availability Quantity
1mg USD 200  USD200 In stock
5mg USD 550  USD550 In stock
10mg USD 800  USD800 In stock
25mg USD 1200  USD1200 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PROTAC IRAK4 degrader-7 (Compound I-417) is a potentially first-in-class, orally active PROTAC IRAK4 degrader with antitumor activity for studies related to hidradenitis suppurativa (HS) and atopic dermatitis (AD).

Chemical Information
Molecular Weight 865.93
Formula C44H49F2N11O6
CAS Number 2432994-31-3
Form Solid
Storage Powder -20°C
References

[1] Zi Liu, et al. Mol Biomed. An overview of PROTACs: a promising drug discovery paradigm

[2] Tingting Yao, et al. Int J Mol Sci. Recent Advances in PROTACs for Drug Targeted Protein Research

[3] Robert B Kargbo. ACS Med Chem Lett. PROTAC Degradation of IRAK4 for the Treatment of Cancer

[4] Robert B Kargbo. ACS Med Chem Lett. PROTAC Degradation of IRAK4 for the Treatment of Neurodegenerative and Cardiovascular Diseases

[5] Joao Nunes, et al. ACS Med Chem Lett. Targeting IRAK4 for Degradation with PROTACs

Related PROTAC Products
CR8

CR8 is a potent and selective inhibitor of cyclin dependent kinase (CDK1, 2, 5, 7, and 9).

ARV-393

ARV-393 is an orally active PROTAC degrader targeting BCL6 for studies related to diffuse large B-cell lymphoma. ARV-393 utilizes the ubiquitin-proteasome system to target the degradation of BCL6.

ARV-766

ARV-766 is an orally active and potent proteolysis targeting chimera (PROTAC) protein degrader. ARV-766 degrades wild-type androgen receptor (AR) but also relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations. ARV-766 has the potential to be first- and best-in class PROTAC AR degrader in mCRPC.

Indisulam

Indisulam is a carbonic anhydrase inibitor and antitumor CDK inhibitor. Indisulam targets the G1 phase of the cell cycle by depleting cyclin E. inducing p53 and p21, and inhibiting CDK2, causing a blockade in the G1/S transition.

dBET6

dBET6 is a highly potent, selective and cell-permeable PROTAC connected by ligands for Cereblon and BET, with an IC50 of 14 nM, and has antitumor activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: PROTAC IRAK4 degrader-7 , KT-474; SAR444656 supplier, PROTAC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.